{
    "Humans": 0.0084635663,
    "Female": 0.0055675051,
    "Breast Neoplasms": 0.0039817896,
    "Middle Aged": 0.0030096338,
    "Aged": 0.0024670536,
    "Adult": 0.0023730111,
    "breast cancer": 0.0019704629,
    "Male": 0.0017163057,
    "Neoplasms": 0.0011035037,
    "Prognosis": 0.0010733744,
    "Risk Factors": 0.0009531607,
    "Aged, 80 and over": 0.0009371725,
    "United States": 0.0007920644,
    "Retrospective Studies": 0.0006972505,
    "Animals": 0.0006903977,
    "Mammography": 0.00066196,
    "patients": 0.0006408698,
    "Registries": 0.0006244415,
    "Neoplasm Staging": 0.0006081822,
    "Breast cancer": 0.0006076086,
    "Incidence": 0.000583849,
    "Biomarkers, Tumor": 0.0005424526,
    "Algorithms": 0.0005362372,
    "Cohort Studies": 0.0004748343,
    "Gene Expression Regulation, Neoplastic": 0.0004676206,
    "Gene Expression Profiling": 0.0004653407,
    "Young Adult": 0.0004603489,
    "Treatment Outcome": 0.0004523761,
    "cancer": 0.0004486822,
    "Follow-Up Studies": 0.0004172398,
    "Age Factors": 0.0004142255,
    "Adolescent": 0.0004132148,
    "Survival Rate": 0.0004052583,
    "Cell Line, Tumor": 0.0003995676,
    "Survival Analysis": 0.0003880711,
    "Mass Screening": 0.0003868289,
    "Receptors, Estrogen": 0.0003794275,
    "Genetic Predisposition to Disease": 0.0003765307,
    "prognosis": 0.0003715817,
    "Early Detection of Cancer": 0.0003665829,
    "survival": 0.0003621516,
    "Time Factors": 0.0003608109,
    "Case-Control Studies": 0.0003487247,
    "Antineoplastic Agents": 0.0003475939,
    "Reproducibility of Results": 0.0003468743,
    "Neoplasm Recurrence, Local": 0.0003400316,
    "women": 0.000336922,
    "Receptor, ErbB-2": 0.0003356213,
    "Prospective Studies": 0.0003311445,
    "Mutation": 0.0003206387
}